SARIYILDIZ, E. Et Al. 2024. Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry. Acta Medica , vol.55, no.3 , 214-221.

SARIYILDIZ, E., ÜNALDI, E., KILIÇ, L., KARADAĞ, Ö., KALYONCU, U., ERTENLİ, A. İ., ... KİRAZ, S.(2024). Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry. Acta Medica , vol.55, no.3, 214-221.

SARIYILDIZ, Emine Et Al. "Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry," Acta Medica , vol.55, no.3, 214-221, 2024

SARIYILDIZ, Emine Et Al. "Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry." Acta Medica , vol.55, no.3, pp.214-221, 2024

SARIYILDIZ, E. Et Al. (2024) . "Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry." Acta Medica , vol.55, no.3, pp.214-221.

@article{article, author={Emine SARIYILDIZ Et Al. }, title={Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry}, journal={Acta Medica}, year=2024, pages={214-221} }